S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
Log in

OTCMKTS:EVKIFEvonik Industries Stock Price, Forecast & News

$29.18
+0.78 (+2.75 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$29.18
Now: $29.18
$29.57
50-Day Range
$24.33
MA: $27.10
$29.18
52-Week Range
$17.32
Now: $29.18
$30.72
Volume7 shs
Average Volume975 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products. The Resource Efficiency segment provides high-performance materials and specialty additives, such as hydrogen peroxide, activated nickel catalysts, precious metal powder catalysts, oil and fat hydrogenation catalysts, amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, organically modified silicones, isophorone chemistry, PEEK, polyamide 12, oil additives, organosilanes, chlorosilanes, fumed silicas, fumed metal oxides, precipitated silicas, and matting agents for the automotive, paints, coatings, adhesives, construction, and various other sectors. The Performance Materials segment produces polymer materials and intermediates, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, TAA and TAA derivatives, and methacrylate monomers and polymers for rubber, plastics, and agriculture industries. The Services segment provides site management, utilities and waste management, technical, process technology, engineering, and logistics services. The company is headquartered in Essen, Germany. Evonik Industries AG is a subsidiary of RAG-Stiftung.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
Current SymbolOTCMKTS:EVKIF
CUSIPN/A
CIKN/A
Phone49 201 177 3146

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees36,043
Next Earnings DateN/A
OptionableNot Optionable
$29.18
+0.78 (+2.75 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EVKIF News and Ratings via Email

Sign-up to receive the latest news and ratings for EVKIF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Evonik Industries (OTCMKTS:EVKIF) Frequently Asked Questions

How has Evonik Industries' stock price been impacted by Coronavirus?

Evonik Industries' stock was trading at $23.2879 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EVKIF stock has increased by 25.3% and is now trading at $29.1812.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Evonik Industries?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evonik Industries in the last year. There are currently 1 sell rating, 3 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Evonik Industries
.

Has Evonik Industries been receiving favorable news coverage?

Media stories about EVKIF stock have been trending somewhat negative on Friday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Evonik Industries earned a daily sentiment score of -1.3 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about Evonik Industries
.

Are investors shorting Evonik Industries?

Evonik Industries saw a increase in short interest during the month of June. As of June 15th, there was short interest totaling 1,444,100 shares, an increase of 157.3% from the May 31st total of 561,200 shares. Based on an average daily trading volume, of 1,400 shares, the short-interest ratio is presently 1,031.5 days.
View Evonik Industries' Short Interest
.

Who are some of Evonik Industries' key competitors?

Who are Evonik Industries' key executives?

Evonik Industries' management team includes the following people:
  • Mr. Christian Kullmann, CEO & Chairman of the Exec. Board (Age 50)
  • Dr. Harald Schwager, Deputy Chairman of the Exec. Board (Age 59)
  • Ms. Ute Wolf, CFO & Member of Exec. Board (Age 51)
  • Mr. Thomas Wessel, Chief Human Resource Officer, Industrial Relations Director & Member of Exec. Board (Age 56)
  • Dr. Wilfried Ostendorf, Head of Production and Technology

What is Evonik Industries' stock symbol?

Evonik Industries trades on the OTCMKTS under the ticker symbol "EVKIF."

How do I buy shares of Evonik Industries?

Shares of EVKIF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Evonik Industries' stock price today?

One share of EVKIF stock can currently be purchased for approximately $29.18.

What is Evonik Industries' official website?

The official website for Evonik Industries is www.evonik.com.

How can I contact Evonik Industries?

The company can be reached via phone at 49 201 177 3146.

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.